Neogenomics Inc. (neo 0.25 01/15/28)

13F holders, Q1 2025 (March 31)
2holders −1
0new positions
1sold out
$0.86avg. 13F price*

At the end of Q1 2025, 2 institutions reported holding Neogenomics Inc. (neo 0.25 01/15/28) in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 1 sold out. The largest holders were New York State Common Retirement Fund ($3.7M) and Private Management Group Inc. ($61K).

Company
Neogenomics Inc. (neo 0.25 01/15/28)
CUSIP
64049MAB6
Latest filing quarter
Q2 2026

History

Number of 13F holders

0123 Q1 2024: 1Q1 2024Q2 2024: 3Q2 2024Q3 2024: 3Q3 2024Q4 2024: 3Q4 2024Q1 2025: 2Q1 2025Q2 2025: 2Q2 2025Q3 2025: 2Q3 2025Q4 2025: 2Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions0$0
Exits1$50K

All 13F filers, Q4 2024 → Q1 2025: 60,000 shares sold, net −60,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

New York State Common Retirement Fund 0.01% No change 4,297,000 $3.7M
Private Management Group Inc. 0.00% No change 72,000 $61K

"% of holder's portfolio" is NEOGENOMICS INC (NEO 0.25 01/15/28)'s weight in each manager's 13F, not the share of Neogenomics Inc. (neo 0.25 01/15/28) the manager owns.